✦ LIBER ✦

Treatment of Brain Radiation Necrosis with Mouse-Nerve Growth Factor: A Phase II Trial

✍ Scribed by Wang, X.; Ying, H.; Zhou, Z.; He, X.; Hu, C.

Book ID: 122970319
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.931

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of recombinant tumor ne

A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma

✍ Nancy Kemeny; Barry Childs; William Larchian; Kim Rosado; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Subchronic treatment with lithium increa

Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats

✍ Hellweg, R; Lang, U E; Nagel, M; Baumgartner, A 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Phase I/II study of IV topotecan in comb

Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases

✍ Alireza Mirmiran; Edward McClay; Matthew A. Spear 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 212 KB

A Phase II Trial of Humanized Anti-Vascu

A Phase II Trial of Humanized Anti-Vascular Endothelial Growth Factor Antibody for the Treatment of Androgen-Independent Prostate Cancer

✍ David M. Reese; Paige Fratesi; Michelle Corry; William Novotny; Eric Holmgren; E 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

A Phase I trial of continuous hypertherm

A Phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis

✍ David L. Bartlett; Joseph F. Buell; Steven K. Libutti; Eddie Reed; Kang Bo Lee; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## BACKGROUND. Tumor necrosis factor (TNF), hyperthermia, and cisplatin have synergistic cytotoxicity against cancer cells in vitro. This combination may be well suited to the regional treatment of peritoneal tumor spread in patients. Continuous hyperthermic peritoneal perfusion (CHPP) is a techni

Tanezumab, an Anti-Nerve Growth Factor (

Tanezumab, an Anti-Nerve Growth Factor (NGF) antibody, for the treatment of chronic low back pain (CLBP) – a randomized, controlled, double-blind, phase 2 trial

✍ N. Katz; D. Borenstein; C. Birbara; C. Bramson; M. Nemeth; M. Smith; M. Brown 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB